Table 2

Demographic data and data related to serum concentration of ARI and DARI in men in different groups

CharacteristicARI
group
(n=43)
Comedication
group (n=63)
χ2P valueComedication
group (n=63)
CLZ (n=31)RIP (n=7)QTP (n=8)OLZ (n=17)χ2P value
Demographic
 Age, yearsMean (SD)Mean (SD)tP valueMean (SD)Mean (SD)Mean (SD)Mean (SD)FP value
36.1 (10.4)42.3 (12.6)−4.23<0.00145.6 (11.2)29.8 (12.0)34.6 (15.8)41.5 (12.0)10.78<0.001
Data related to serum concentration
 ARI dose, mg/d21.4 (7.2)20.5 (7.1)0.930.3619.9 (5.5)25.9 (12.8)20.0 (3.8)20.4 (8.0)1.960.10
 Comedication dose, mg/dmedian
(IQR 25–75)
median
(IQR 25–75)
χ2P valuemedian
(IQR 25–75)
median
(IQR 25–75)
median
(IQR 25–75)
median
(IQR 25–75)
χ2P value
113.0 (100.0–163.0)2.0 (2.0–3.0)200.0 (150.0–300.0)10.0 (7.5–10.0)
 ARI concentration, ng/ml233.6 (134.3–339.5)237.9 (140.6–316.5)0.150.70245.7 (166.6–322.4)260.9 (126.1–324.5)166.1 (124.4–303.8)237.0 (137.4–304.6)1.340.86
 DARI concentration, ng/ml94.1 (47.5–176.5)110.5 (65.6–151.9)2.240.14115.3 (80.4–163.5)89.7 (36.1–171.0)100.4 (62.0–139.4)104.3 (65.0–130.7)6.570.16
 ARI+DARI concentration, ng/ml331.5 (199.2–516.8)336.1 (227.0–465.7)0.020.90378.6 (264.5–488.7)384.1 (184.0–544.2)265.0 (211.1–443.2)352.4 (210.1–471.9)2.480.65
 ARI concentration/ARI dose, d/L12.0 (7.6–16.1)11.8 (8.2–15.3)0.030.8612.3 (8.6–15.4)10.2 (4.4–17.1)8.5 (5.4–16.2)11.8 (8.0–14.9)1.230.87
 DARI concentration/ARI dose, d/L4.8 (2.5–8.3)5.5 (3.7–7.8)2.450.126.8 (4.4–8.2)2.3 (1.8–7.8)5.0 (3.1–8.0)5.1 (3.4–6.3)9.410.05
 ARI+DARI concentration/ARI dose, d/L16.9 (10.7–24.2)18.1 (11.9–23.1)0.150.7019.6 (12.9–23.2)20.8 (6.0–27.2)13.3 (10.5–23.7)16.4 (11.6–22.2)2.680.61
  • ARI, aripiprazole; CLZ, clozapine; DARI, dehydroaripiprazole; IQR, interquartile range; OLZ, olanzapine; QTP, quetiapine; RIP, risperidone; SD, standard deviation .